Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Mather

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
European Journal of Nuclear Medicine|August 1, 1993
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancerM Granowska, K E Britton, S J Mather, et al.
Clinical Endocrinology|February 1, 1992
Pituitary imaging using a labelled somatostatin analogue in acromegalyE Ur, S J Mather, J Bomanji, et al.
Gynecologic Oncology|September 1, 1990
Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3T W Jobling, M Granowska, K E Britton, et al.
British Journal of Cancer|April 16, 2002
Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1A R Al-Yasi, M J Carroll, D Ellison, et al.
Cancer Research|September 1, 1987
Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administrationB G Ward, S J Mather, L R Hawkins, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 1999
Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigenL M Stewart, S Young, G Watson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 19, 2004
Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT)R J Francis, S J Mather, K Chester, et al.
British Journal of Urology|March 1, 1996
Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351M R Feneley, V U Chengazi, R S Kirby, et al.
British Journal of Cancer|February 12, 1998
99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detectionL Biassoni, M Granowska, M J Carroll, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1997
Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351)V U Chengazi, M R Feneley, D Ellison, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Nuclear Medicine|August 1, 1993
Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancerM Granowska, K E Britton, S J Mather, et al.
Clinical Endocrinology|February 1, 1992
Pituitary imaging using a labelled somatostatin analogue in acromegalyE Ur, S J Mather, J Bomanji, et al.
Gynecologic Oncology|September 1, 1990
Radioimmunoscintigraphy of ovarian tumors using a new monoclonal antibody, SM-3T W Jobling, M Granowska, K E Britton, et al.
British Journal of Cancer|April 16, 2002
Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1A R Al-Yasi, M J Carroll, D Ellison, et al.
Cancer Research|September 1, 1987
Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administrationB G Ward, S J Mather, L R Hawkins, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 1999
Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigenL M Stewart, S Young, G Watson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 19, 2004
Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT)R J Francis, S J Mather, K Chester, et al.
British Journal of Urology|March 1, 1996
Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351M R Feneley, V U Chengazi, R S Kirby, et al.
British Journal of Cancer|February 12, 1998
99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detectionL Biassoni, M Granowska, M J Carroll, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1997
Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351)V U Chengazi, M R Feneley, D Ellison, et al.
Pageof 10